Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
Epic Aura for CRC Screening: A Real-World Perspective
Natalia Usoltseva MD, FACP, MHA
Improving CRC Screening Conversations in Primary Care
Improving CRC Screening Workflows: A PCP's Recommendations
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
Nadia Harbeck, MD, PhD
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Managing Brain Metastases Through Multidisciplinary Team Collaboration
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Brian P. McDonough, MD, FAAFP
Madison Conces, MD
Midhun Malla, MD
Making Mechanism-Based Treatment Decisions in cGVHD
Alicia Lieberman, MD, MS
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Guru P. Sonpavde, MD
Preventing Colorectal Cancer with Smart Screening
Harish Gagneja, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.